H, C., MK, J., EYM, Y., Z, W., M, P., WM, U., . . . MTN, L. (2022). CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia. Cell proliferation, 55(9), e13255. https://doi.org/10.1111/cpr.13255
Chicago Style (17th ed.) CitationH, Chen, et al. "CD33-targeting Extracellular Vesicles Deliver Antisense Oligonucleotides Against FLT3-ITD and MiR-125b for Specific Treatment of Acute Myeloid Leukaemia." Cell Proliferation 55, no. 9 (2022): e13255. https://doi.org/10.1111/cpr.13255.
MLA (9th ed.) CitationH, Chen, et al. "CD33-targeting Extracellular Vesicles Deliver Antisense Oligonucleotides Against FLT3-ITD and MiR-125b for Specific Treatment of Acute Myeloid Leukaemia." Cell Proliferation, vol. 55, no. 9, 2022, p. e13255, https://doi.org/10.1111/cpr.13255.